Serum cholesterol and lipid peroxidation are decreased by melatonin in diet-induced hypercholesterolemic rats

Journal of Pineal Research

Volumn 28, Issue 3, 2000, Pages 150-155

  Hoyos, Marta ^a   Guerrero, Juan M ^a   Perez Cano, Ramon ^a   Olivan, Josefina ^a   Fabiani, Fernando ^a   Garcia Pergañeda, Antonio ^a   Osuna, Carmen ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Antioxidants; Cholesterol; Melatonin; Pineal

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; MELATONIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; HORMONE ACTION; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; LIVER; MALE; NONHUMAN; RAT; SPLEEN;

EID: 0034068733     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-079x.2001.280304.x     Document Type: Article

References (36)

1. Aoyama, H., N. Mori, W. Mori (1988) Effects ofraclalonin on genetic hypercholesterolemia in rats. Atherosclerosis 69:269-272.
2. Bartsch, C., H. Bartsch, U. Fuchs, T.H. Lippert, O. Bellmann, D. Gupta (1989) Stage-dependent depression of melatonin in patients with primary breast cancer: Correlation with prolactin, thyroid stimulating hormone and steroid receptors. Cancer 64:426-433.
3. Bradford, M. (1976) A rapid and sensitive method for quantification of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:248-253.
4. Brzezinski, A. (1997) Melatonin in humans. New Engl. J. Med. 336:186-195.
5. Chan, T.Y., P.L. Tang (1995) Effect of melatonin on the maintenance of cholesterol homeostasis in the rat. Endocr. Res. 21:681-696.
6. Cuzzocrea, S., B. Zingarelli, G. Costantino, A.P. Caputi (1998) Protective effect of melatonin in a non-septic shock model induced by zymosan in the rat. J. Pineal Res. 25:24-33.
7. Dollins, A.B., I. Zhdanova, R.J. Wurtman, H.J. Lynch, M.H. Dend (1994) Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc. Natl. Acad. Sci. U.S.A. 91:1824-1828.
8. Escames, G., J.M. Guerrero, R.J. Reiter, J.J. Garcia, A. Muñoz-Hoyos, G.G. Ortiz, C.S. Oh (1997) Melatonin and vitamin E limit nitric oxide-induced lipid peroxidation in rat brain homogenates. Neurosci. Lett. 230:147-150.
9. Esquifino, A., C. Agrasal, E. Velazquez, M.A. Villanua, D.P. Cardinali (1997) Effect of melatonin on serum cholesterol and phospholipid levels, and on prolactin, thyroid-stimulating hormone and thyroid hormone levels, in hyperprolactinemic rats. Life Sci. 61:1051-1058.
10. Garcia, J.J., R.J. Reiter, J.M. Guerrero, G. Escames, B.P. Yu, C.S. Oh, A. Muñoz-Hoyos (1997) Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett. 408:297-300.
11. Garcia-MauriñO, S, M.G. Gonzalez-Haba, J.R. Calvo, M. Rafii-El-Idrissi, V. Sánchez-Margalet, R. Goberna, J.M. Guerrero (1997) Melatonin enhances IL-2, IL-6 and IFNgamma production by human circulating CD4 + cells: A possible nuclear receptor-mediated mechanism involving Th1 lymphocytes and monocytes. J. Immunol. 159:574-581.
12. García-Mauriño, S., M.G. Gonzalez-Haba, J.R. Calvo, R. Goberna, J.M. Guerrero (1998) Involvement of nuclear binding sites for melatonin in the regulation of IL-2 and IL-6 production by human blood mononuclear cells. J. NEuroimmunol. 92:76-84.
13. García-Pergañeda, A., D. Pozo, J.M. Guerrero, J.R. Calvo (1997) Signal transduction for melatonin in human lymphocytes: Involvement of a pertussis-toxin sensitive G protein. J. Immunol. 159:3774-3781.
14. Goldman, B.D. (1983) The physiology of melatonin in mammals. Pineal Res. Rev. 1:145-182.
15. Harmov, I., P. Lavie, M. Laudon, P. Herer, N. Zisapel (1995) Melatonin replacement therapy of elderly insomniacs. Sleep 18:598-603.
16. Hill, S.M., D.E. Blask (1988) Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res. 48:6121-6126.
17. Lewy, A.J., S. Ahmed, J.M. Latham-Jackson, R.L. Sack (1992) Melatonin phase shifts human circadian rhythm according to a phase response curve. Chronobiol. Int. 9:380-392.
18. Maestroni, G.J.M. (1993) The immunoendocrine role of melatonin. J. Pineal Res. 14:1-10.
19. Montilla, P., I. Tunez, M.C. MuñOz, A. Lopez, J.V. Soria (1997) Hyperlipidemic nephropathy induced by adriamycin: Effect of melatonin administration. Nephron 76:345-350.
20. Mori, N., H. Aoyama, T. Murase, W. Mori (1989) Antihypercholesterolemic effect of melatonin in rats. Acta Pathol. Jpn. 39:613-618.
21. Morrey, K.M., J.A. Mclachan, C.D. Serkin, O. Bakouche. (1994) Activation of human monocytes by the pineal hormone melatonin. J. Immunol. 153:2671-2680.
22. Müller-Wieland, D., B. Behnke, K. Koopmann, W. Krone (1994) Melatonin inhibits LDL receptor activity and cholesterol synthesis in freshly isolated human mononuclear leukocytes. Biochem. Biophys. Res. Commun. 203:416-421.
23. Fieri, C., M. Marra, R. Gaspar, S. Damjanovich (1996) Melatonin protects LDL from oxidation but does not prevents the apolipoprotein derivatization. Biochem. Biophys. Res. Commun. 222:256-260.
24. Pittalis, S., P. Lissoni, L. Giani, M. Casati, N. Kropacek, S. Orfano, F. Giavolucci, D. Merlini (1997) Effect of a chronic therapy with the pineal hormone melatonin on cholesterol levels in idiopathic hypercholesterolemic patients. Recenti. Prog. Med. 88:401-402.
25. Pozo, D., M. Delgado, J.M. Fernandez-Santos, J.R. Calvo, R.P. Gomariz, I. Martin-Lacave, G.G. Ortiz, J.M. Guerrero (1997) Expression of the membrane melatonin receptor mRNA in T und B subsets of lymphocytes from rat thymus and spleen. FASEB J. 11:466-473.
26. Princ, F.G., A.G. Maxit, C. Cardalda, A. Batlle, A.A. Juknat (1998) In vivo protection by melatonin against delta-aminolevulinic acid-induced oxidativc damage and its antioxidant effect on the activity of haem enzymes. J. Pineal Res. 24:1-8.
27. 125I]iodomelatonin by rat spleen crude membranes: Day night variations and effect of pinealectomy and continuous light exposure. J. Pineal Res. 20:33-38.
28. Reiter, R.J. (1991) Pineal melatonin: Cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12:151-180.
29. Reiter, R.J. (1992) The aging pineal gland and its physiological consequences. BioEssays 14:169-175.
30. Reiter, R.J. (1998) Oxidative damage in the central nervous system: Protection by melatonin. Prog. Neurobiol. 56:359 384.
31. 2-induced lipid peroxidation in homogenates of different rat brain regions. J. Pineal Res. 19:51-56.
32. Tan, D.X., L.D. Chen, B. Poeggeler, L.C. Manchester, R.J. Reiter (1993a) Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocr. J. 1:57-60.
33. Tan, D.X., B. Poeggeler, R.J. Reiter, L.D. Chen, S. Chen, L.C. Manchester, L.R. Barlow-Walden (1993b) The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett. 70:65-71.
34. Tan, D.X., R.J. Reiter, L.D. Chen, B. Poeggeler, L.C. Manchester, L.R. Barlow-Walden (1994) Both physiological and pharmacological levels of melatonin reduces DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 15:215-218.
35. Vaughan, M.K., B.A. Richardson, C.M. Craft, M.C. Powanda, R.J. Reiter (1982) Interactions of ageing, photoperiod and melatonin on plasma thyroid hormones and cholesterol levels in female Syrian hamsters (Mesocricetus auratus). Gerontology 28:345-353.
36. Vaughan, M.K., B.A. Richardson, L.Y. Johnson, L.J. Petterborg, M.C. Powanda, R.J. Reiter, I. Smith (1983) Natural and synthetic analogues of melatonin and related compounds. II. Effects on plasma thyroid hormones and cholesterol levels in male Syrian hamsters. J. Neural Transm. 56:279-291.